Who is iCAD?

iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.

Recent News

January 7, 2019
Long-Term Study of 1,000 Tumors Demonstrates Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

December 27, 2018
iCAD Announces CFO Transition

December 20, 2018
iCAD, Inc. Announces $7.0 Million Private Placement of Unsecured Subordinated Convertible Debentures

December 7, 2018
iCAD Announces FDA Clearance of ProFound AI™ for Digital Breast Tomosynthesis

November 26, 2018
iCAD Unveils ProFound AI™ for Digital Breast Tomosynthesis at RSNA 2018

CONNECT

© 2018, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.